Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03855111 · ClinicalTrials.gov registry record · NA
Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain
A NA study of Pain and HIV/AIDS, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
- 1
- Study location
NCT03855111: Completed NA study of Pain and HIV/AIDS, sponsored by New York University.
NCT03855111 is a NA study of Pain and HIV/AIDS that has completed, run by New York University. The registered enrollment target is 196 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03855111, a NA study of Pain and HIV/AIDS, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with HIV. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. In HIV there are no FDA-approved drugs for this indication. This study assesses in a randomized controlled clinical trial, the efficacy of novel non-pharmacologic pain management approaches to reduce HIV-related DSP pain and improve quality of life.
Primary Outcome
The GPS is a scale of sensory pain. Participants rate their DSP pain by selecting one of 13 words to describe their average and worst DSP pain. Scores on a scale: "Nothing"=0 to "Extremely intense"=12
Conditions Studied
Interventions
- OTHER Standard Acupuncture / Moxibustion
- OTHER Individualized (Tailored) Active Acupuncture / Moxibustion
Study Locations (1)
New York
- New York University, Division of Special Studies in Symptom Management - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2024-10-21 |
| Phase | NA |
What the finished NCT03855111 record still lists
NCT03855111 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (36% lower).
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard Acupuncture / Moxibustion is the first listed.
NCT03855111 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03855111 about?
NCT03855111 is a clinical study titled "Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain". Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with HIV. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. In HIV th...
What is the current status of trial NCT03855111?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2019-01-14. Estimated completion is 2024-10-21.
What conditions does trial NCT03855111 study?
This clinical trial studies the following conditions: Pain, HIV/AIDS, Neuropathic Pain, HIV Neuropathy.
What interventions are being tested in trial NCT03855111?
The interventions under investigation include: Standard Acupuncture / Moxibustion (OTHER), Individualized (Tailored) Active Acupuncture / Moxibustion (OTHER).
Who is sponsoring clinical trial NCT03855111?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03855111 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03855111's enrollment target sits among peer trials
196 92nd of 374 higher than 283 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI